Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome.

Medical mycology - 1 Sept 2008

Atkinson Bradley J, Lewis Russell E, Kontoyiannis Dimitrios P

Abstract excerpt

Candida lusitaniae, a Candida species frequently resistant to amphotericin B (AMB), is a rare cause of candidemia. The clinical significance of this in vitro resistant phenotype, the risk factors for, and the clinical presentation of C. lusitaniae fungemia in comparison with those of Candida albicans have not been completely characterized. We reviewed 13 consecutive cases of C. lusitaniae fungemia in cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amphotericin B
Share to Antifungal Agents
Share to Candida

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Candidiasis

Share to Drug Resistance, Fungal

Share to Neoplasms

Share to Risk Factors

Share to Treatment Outcome

Source

Identifiers

PMID: 19180749
DOI: 10.1080/13693780801968571

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome.PMID 19180749Read ↗

Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy.Semantic proximity Read ↗

High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance.Semantic proximity Read ↗

In Vivo Efficacy of Amphotericin B against Four Candida auris CladesSemantic proximity Read ↗

Candida guilliermondii fungemia in patients with hematologic malignancies.Semantic proximity Read ↗

Evolution of drug resistance in an antifungal-naive chronic Candida lusitaniae infectionSemantic proximity Read ↗

Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.Semantic proximity Read ↗

Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.Semantic proximity Read ↗

Identification of Virulence Factors in Isolates of Candida haemulonii, Candida albicans and Clavispora lusitaniae with Low Susceptibility and Resistance to Fluconazole and Amphotericin BSemantic proximity Read ↗

The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata.Semantic proximity Read ↗

Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistantSaccharomyces cerevisiaeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.